Series C led by ARCH Venture Partners and TCGX with significant participation from existing and new investors Financing extends Arbor’s cash runway into 2027 and supports the clinical development of…
The tRNA biotech is closing “following careful consideration of potential paths forward and strategic factors,” CEO Leslie Williams said. (Michael Edwards/GettyImages) HC Bioscience is shutting down after conducting preclinical models…
Explore how integrating genomic and proteomic data is driving advancements in personalized medicine. Article :Published: March 10, 2025 | Thomas Moehring, PhD As healthcare shifts to embrace personalized medicine, translational omics is…
The secret? Halt a cell’s reverse-aging process at the precise moment before it reverts to its embryonic form.By Monique BrouillettePublished: May 06, 2022 12:03 PM EDT Shinya Yamanaka won the Nobel Prize…
Termination of a Vertex deal comes as Verve Therapeutics' other big partnership nears a key moment. (Getty Images) Vertex has backed out of its in vivo gene editing collaboration with Verve Therapeutics…
Trying to find common ground during a “Biotech Hangout” discussion in January about whether China’s biotech growth should be curbed, TD Cowen analyst Yaron Weber argued that an increasingly innovative…